European Respiratory Review is the flagship review journal of the European Respiratory Society, published quarterly since 1991 and fully open access with a 2025 impact factor of 10.8.《欧洲呼吸评论》（European Respiratory Review）是欧洲呼吸学会（European Respiratory Society）的旗舰综述期刊，1991年创刊，季刊出版，全文开放获取，2025年影响因子为10.8
*It publishes state-of-the-art reviews, updates, meeting proceedings, editorials and correspondence on topical issues in respiratory medicine, science and surgery.该刊发表呼吸医学、呼吸科学与呼吸外科热点问题的最新综述、进展更新、会议纪要、社论与通讯
*Thematic coverage includes tuberculosis, chronic obstructive pulmonary disease, cystic fibrosis, respiratory infections, thoracic oncology and sleep-disordered breathing.主题覆盖结核病、慢性阻塞性肺疾病、囊性纤维化、呼吸道感染、胸部肿瘤及睡眠呼吸障碍
*Reviews are largely commissioned from international experts and written for clinicians, allied health professionals and lung scientists alike.综述多由国际专家受邀撰写，面向临床医师、相关卫生专业人员与肺科学研究者
*The journal also runs themed series and updates that summarise the most important recent research findings and published studies.该刊设有专题系列与进展更新栏目，概括近期最重要的研究发现与已发表研究
*All material is subject to independent peer review, and correspondence on published items is encouraged by the Chief Editor.所有内容均经独立同行评审，主编鼓励就已发表内容提交来函讨论
*Articles are free to read and to reuse under Creative Commons licences and are preserved through the LOCKSS and CLOCKSS archives.论文按（Creative Commons）许可免费阅读与再利用，并通过（LOCKSS）与（CLOCKSS）存档保存
*Publication began with volume 1, review number 1 in March 1991 under the auspices of the European Respiratory Society.该刊于1991年3月以第1卷第1期创刊，由欧洲呼吸学会（European Respiratory Society）主办
*The journal website became open access in June 2007, opening the full archive to readers worldwide.2007年6月该刊网站转为开放获取，全部过刊向全球读者免费开放
*In 2009 the format was substantially restructured to admit sponsored symposia content and unsolicited submissions alongside commissioned reviews.2009年该刊大幅改版，在约稿综述之外接纳会议赞助内容与自由来稿[1]
*The journal was selected for MEDLINE indexing in 2012 and entered the Science Citation Index Expanded in 2018.该刊于2012年被（MEDLINE）收录，并于2018年进入科学引文索引扩展版（SCIE）[2]
*Its debut impact factor of 4.929 was announced in 2019 and it has since ranked in the first quartile of respiratory system journals.2019年该刊公布首个影响因子4.929，此后在呼吸系统类期刊中稳居第一四分位（Q1）
*Previous Chief Editors have included Marc Humbert, Vincent Cottin, Sergio Harari, Yochai Adir and Renata Riha.历任主编包括（Marc Humbert）、（Vincent Cottin）、（Sergio Harari）、（Yochai Adir）与（Renata Riha）
*Rory E. Morty of Heidelberg University Hospital has held the Chief Editor post since October 2024 on a three-year mandate.现任主编为海德堡大学医院（Heidelberg University Hospital）的（Rory E. Morty），自2024年10月起任职，任期三年
*Before taking the post he served as Editor-in-Chief of the American Journal of Physiology-Lung Cell and Molecular Physiology from 2018 to 2023.履新前他于2018至2023年任《美国生理学杂志-肺细胞与分子生理学》（American Journal of Physiology-Lung Cell and Molecular Physiology）主编
*The board is international, with section editors and associate editors based across Europe, North America, Asia and Oceania.编委会具国际性，栏目编辑与副编辑分布于欧洲、北美、亚洲及大洋洲多地
*Members named on the journal board listing include Stefano Nava and Obianuju B. Ozoh.编委名单包括（Stefano Nava）与（Obianuju B. Ozoh）等人
*Manuscripts are handled through the ScholarOne submission site and the ERS publications office is located in Sheffield.稿件经（ScholarOne）在线系统处理，欧洲呼吸学会出版办公室设于谢菲尔德（Sheffield）
*A call for the next Chief Editor was issued in 2026 for a term beginning in October 2027 after a year of shadowing.2026年该刊启动下一任主编遴选，任期自2027年10月开始，此前设一年见习期